ESR1 and breast cancer: CNOT7 expression across different BC subtypes has also been retrieved from publicly available datasets (Figure S6), where a significantly higher expression of CNOT7 was associated with grade 3 BC, basal molecular subtype, and ER and PR receptor negativity, supporting the data obtained from our cohort.